Skip to main content

Table 2 Detailed distribution by 5 CGG repeat bands up through the premutation in patients with POI, DOR and controls

From: The significance of FMR1 CGG repeats in Chinese women with premature ovarian insufficiency and diminished ovarian reserve

FMR1 CGG Repeats

N

<25

25–29

30–34

35–39

40–44

45–54 (Intermediate)

55–199 (Premutation)

Allele1

 POI group, N (%)

124

2 (1.6)

65 (52.4)

52 (41.9)

4 (3.2)

1 (0.8)

0

0

  Age at menopause, yrs., mean (SD)

 

16.5 (2.1)

28.9 (7.3)

28.7 (6.5)

23.5 (6)

22

  

  FSH (IU/l), mean (SD)

 

95.2 (43.3)

79 (36.2)

81.4 (38.5)

67.5 (34.9)

129.3

  

  AMH (ng/ml), mean (SD)

 

0

0.1 (0.3)

0 (0.1)

0

0

  

 DOR group, N (%)

57

5 (8.8)

22 (38.6)

29 (50.9)

1 (1.8)

0

0

0

  FSH (IU/l), mean (SD)

 

17.8 (8.8)

15.5 (4.7)

14.1 (3.9)

16.9

   

  AMH (ng/ml), mean (SD)

 

1.0 (0.9)

0.7 (0.6)

0.8 (0.8)

0.9

   

 Control group, N (%)

111

9 (8.1)

24 (21.6)

72 (64.9)

5 (4.5)

1 (0.9)

0

0

  Age at menopause, yrs., mean (SD)

 

52 (2)

50.5 (3.3)

50.5 (2.9)

52.8 (4)

51.0

  

  FSH (IU/l), mean (SD)

 

27.3 (29.5)

26.9 (26.9)

32.5 (32.7)

21.8 (29.6)

52.9

  

Allele2

 POI group, N (%)

124

0

29 (23.4)

56 (45.2)

27 (21.8)

9 (7.3)

1 (0.8)

2 (1.6)

  Age at menopause, yrs., mean (SD)

  

29.6 (6.7)

27.9 (7.4)

27.6 (7.5)

27.8 (5.5)

30.0

35.5 (2.1)

  FSH (IU/l), mean (SD)

  

87.2 (36.8)

80.8 (39.5)

76.5 (36.2)

70.2 (29.6)

110.5

59.1 (10.3)

  AMH (ng/ml), mean (SD)

  

0.0

0.1 (0.3)

0.0

0.0

0.0

0.1 (0.2)

 DOR group, N (%)

57

0

13 (22.8)

30 (52.6)

10 (17.5)

3 (5.3)

1 (1.8)

0

  FSH (IU/l), mean (SD)

  

15.9 (4.7)

14.4 (5.3)

15.3 (3.8)

17.4 (1.5)

11.0

 

  AMH (ng/ml), mean (SD)

  

0.5 (0.6)

0.9 (0.9)

0.9 (0.6)

0.4 (0.3)

0.7

 

 Control group, N (%)

111

0

22 (19.8)

54 (48.6)

26 (23.4)

6 (5.4)

2 (1.8)

1 (0.9)

  Age at menopause, yrs., mean (SD)

  

51.3 (3)

50.5 (3.1)

50.9 (3)

51 (1.9)

46.5 (2.1)

51.0

  FSH (IU/l), mean (SD)

  

23.6 (25.3)

28.8 (30.7)

39.3 (34.5)

15.2 (18.8)

68.9 (32.3)

52.9

  1. Fisher’s exact tests for allele 1: comparison by POI versus control (P < 0.001); comparison by DOR versus control (P = 0.148). Fisher’s exact tests for allele 2: comparison by POI versus control (P = 0.903); comparison by DOR versus control (P = 0.884). The menopausal ages, values of FSH and AMH of women with different CGG repeats groups showed no statistically significant difference (P > 0.05)
  2. Abbreviation: POI Primary ovarian insufficiency, DOR Diminished ovarian reserve, FSH Follicle-stimulating hormone, AMH Anti-mullerian hormone